RTI-7470-44
Chemical compound
Overview[edit | edit source]
RTI-7470-44 is a chemical compound that belongs to the class of phenyltropanes, which are known for their activity as dopamine reuptake inhibitors. This compound is of interest in the field of neuropharmacology due to its potential effects on the central nervous system.
Chemical Structure[edit | edit source]
RTI-7470-44 is characterized by its phenyltropane core, which is a bicyclic structure that includes a tropane ring system. The compound is a derivative of cocaine, modified to enhance its selectivity and potency as a dopamine transporter inhibitor.
Mechanism of Action[edit | edit source]
RTI-7470-44 functions primarily as a dopamine reuptake inhibitor. It binds to the dopamine transporter (DAT) on the presynaptic neuron, preventing the reuptake of dopamine into the neuron. This leads to an increase in the concentration of dopamine in the synaptic cleft, thereby enhancing dopaminergic neurotransmission. This mechanism is similar to that of other stimulant drugs, but RTI-7470-44 is designed to have a more selective action.
Pharmacological Effects[edit | edit source]
The pharmacological effects of RTI-7470-44 are primarily related to its action on the dopamine system. Increased dopaminergic activity can lead to enhanced mood, increased alertness, and improved cognitive function. However, excessive dopaminergic activity can also lead to adverse effects such as anxiety, paranoia, and addiction.
Potential Applications[edit | edit source]
Research into RTI-7470-44 and similar compounds is ongoing, with potential applications in the treatment of disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. The compound's ability to modulate dopamine levels makes it a candidate for further study in these areas.
Safety and Toxicology[edit | edit source]
As with many compounds that affect the central nervous system, the safety profile of RTI-7470-44 is an important consideration. Studies are required to assess its potential for abuse, toxicity, and long-term effects on the brain and body.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
